All Stories

  1. Filamin A in triple negative breast cancer
  2. Chromatin looping links gene expression to the assembly of transcription factories (Review)
  3. Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence
  4. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance
  5. Role of the Androgen Receptor in Gender-Related Cancers
  6. The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment
  7. The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions
  8. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue
  9. The Nerve-Growth Factor Signaling in Gender-Related Cancers
  10. New Approaches Targeting the Invasive Phenotype of Prostate Cancer-Associated Fibroblasts
  11. Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA
  12. Modelling the growth of a PHB producer methanotrophic bacterial strain using a Computational Fluid Dynamic approach: Discontinuous methane feeding strategy
  13. Agri-Food By-Products in Cancer: New Targets and Strategies
  14. Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells
  15. New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models
  16. P-272 Estrogen receptors influence the epithelial-to-mesenchymal transition of pancreatic cancer cell lines
  17. Targeting ERβ to fight melanoma: a new valid approach?
  18. New Insights and Emerging Therapeutic Approaches in Prostate Cancer
  19. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells
  20. Therapeutic potential of TRPM8 antagonists in prostate cancer
  21. Communication between cells: exosomes as a delivery system in prostate cancer
  22. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
  23. Exploiting the mechanism of estrogen-induced transcription to fight breast cancer
  24. Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells
  25. Correction to: The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
  26. The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
  27. Role of the demethylase LSD-1 in cell functions
  28. Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells
  29. Role of ROS generated by nuclear protein modification in the development of cancer
  30. Breast cancer stem cells: the role of sex steroid receptors
  31. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
  32. Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells
  33. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
  34. NGF Induces Proliferation and Aggressiveness In Prostate Cancer Cells.
  35. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
  36. Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
  37. The Androgen Receptor in Breast Cancer
  38. The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
  39. Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach
  40. Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation
  41. Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury
  42. Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis
  43. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer
  44. Faculty of 1000 evaluation for Progesterone receptor modulates ERα action in breast cancer.
  45. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
  46. Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells
  47. Role of JMJD6 in Breast Tumourigenesis
  48. Non-Genomic Androgen Action Regulates Proliferative/Migratory Signaling in Stromal Cells
  49. Faculty of 1000 evaluation for LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
  50. Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells
  51. Abstract 2108: Estrogen non genomic signalling is activated in tamoxifen-resistant breast cancer
  52. Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS
  53. Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer
  54. Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-p21 Pathway
  55. Epigenetic drugs against cancer: an evolving landscape
  56. Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness
  57. A Firmer Understanding of the Effect of Hypergravity on Thyroid Tissue: Cholesterol and Thyrotropin Receptor
  58. Diversin Is Overexpressed in Breast Cancer and Accelerates Cell Proliferation and Invasion
  59. The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1- Hoxa9 Leukemogenesis
  60. Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing
  61. Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
  62. Analysis of Histone Posttranslational Modifications in the Control of Chromatin Plasticity Observed at Estrogen-Responsive Sites in Human Breast Cancer Cells
  63. Phosphoinositide 3-Kinase Assay in Breast Cancer Cell Extracts
  64. Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells
  65. Nuclear Ras2-GTP Controls Invasive Growth in Saccharomyces cerevisiae
  66. Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Antiestrogens by Dephosphorylating Estrogen Receptor at Tyr537
  67. RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer
  68. Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells
  69. Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
  70. Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)
  71. Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer
  72. Faculty of 1000 evaluation for FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade.
  73. Faculty of 1000 evaluation for Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
  74. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA
  75. Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma
  76. Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?
  77. Estradiol Receptor (ER) Chromatin Immunoprecipitation in MCF-7 Cells
  78. p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF
  79. Faculty of 1000 evaluation for Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
  80. The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
  81. A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells
  82. Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors
  83. Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
  84. Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by 131I
  85. ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation
  86. Faculty of 1000 evaluation for Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.
  87. Faculty of 1000 evaluation for Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
  88. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells
  89. Advances in Rapid Sex-Steroid Action
  90. Non-genomic Action of Steroid Hormones: More Questions than Answers
  91. Faculty of 1000 evaluation for Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
  92. Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association
  93. Analysis of Androgen Receptor Rapid Actions in Cellular Signaling Pathways: Receptor/Src Association
  94. Targeting rapid action of sex steroid receptors in breast and prostate cancers
  95. Steroid signaling activation and intracellular localization of sex steroid receptors
  96. Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines
  97. Faculty of 1000 evaluation for c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.
  98. Cell proliferation regulated by estradiol receptor: Therapeutic implications
  99. Faculty of 1000 evaluation for miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
  100. Prostate cancer stem cells: the role of androgen and estrogen receptors
  101. Non-Genomic Action of Sex Steroid Hormones
  102. Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells
  103. Faculty of 1000 evaluation for A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.
  104. Faculty of 1000 evaluation for Tumours with PI3K activation are resistant to dietary restriction.
  105. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: Targeting the association of Src with steroid receptors
  106. Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells
  107. Integrating signals between cAMP and MAPK pathways in breast cancer
  108. Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor   Tyrosine-Phosphorylated Peptide
  109. Src-dependent signalling pathway regulation by sex-steroid hormones: Therapeutic implications
  110. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
  111. Crosstalk between EGFR and Extranuclear Steroid Receptors
  112. p85 regulatory subunit of PI3K mediates cAMP–PKA and estrogens biological effects on growth and survival
  113. Steroid Receptor Regulation of Epidermal Growth Factor Signaling through Src in Breast and Prostate Cancer Cells: Steroid Antagonist Action
  114. Role of Atypical Protein Kinase C in Estradiol-Triggered G1/S Progression of MCF-7 Cells
  115. Rapid signalling pathway activation by androgens in epithelial and stromal cells
  116. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action
  117. Two Domains of the Progesterone Receptor Interact with the Estrogen Receptor and Are Required for Progesterone Activation of the c-Src/Erk Pathway in Mammalian Cells
  118. Interactions of Estrogen Receptors with Signal Cascade Molecules
  119. Sex steroid hormones act as growth factors
  120. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
  121. cAMP signaling selectively influences Ras effectors pathways
  122. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
  123. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
  124. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
  125. Protein Tyrosine Phosphorylation and Estradiol Action
  126. A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers
  127. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
  128. Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells
  129. Properties of a purified estradiol-dependent calf uterus tyrosine kinase
  130. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors
  131. In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor
  132. Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells
  133. Phosphorylation on Tyrosine ofin VitroSynthesized Human Estrogen Receptor Activates Its Hormone Binding
  134. Serine phosphorylation of biosynthetic prourokinase plasminogen activator in human cells
  135. In VitroInteraction of Estradiol Receptor with Ca2+-Calmodulin
  136. Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system.
  137. [54] Calmodulin-stimulated estradiol receptor-tyrosine kinase I
  138. Phosphorylation on tyrosine of oestradiol-17β receptor in uterus and interaction of oestradiol-17β and glucocorticoid receptors with antiphosphotyrosine antibodies
  139. Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody.
  140. Hormone regulation of 17β-estradiol receptor phosphorylation on tyrosine
  141. Activation-inactivation of hormone binding sites of the oestradiol-17β receptor is a multiregulated process
  142. Hypnosis for upper gastrointestinal endoscopy
  143. Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine.
  144. Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17β receptor. role of Ca2+-Calmodulin in the activation of hormone binding sites
  145. Phosphorylation-Dephosphorylation of the Estradiol Receptor Regulates its Hormone Binding Activity
  146. Phosphorylation of calf uterus 17β-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor
  147. Evidence that invivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm
  148. Hormone binding of estradiol-17β receptor: Evidence for its regulation by cytoplasmic phosphorylation and nuclear dephosphorylation. Prevention of dephosphorylation by antiestrogens
  149. Dephosphorylation of oestradiol nuclear receptorin vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens
  150. ATP-dependent enzyme activating hormone binding of estradiol receptor
  151. Inactivation of oestrogen receptor in vitro by nuclear dephosphorylation
  152. In vitro inactivation of oestrogen receptor by nuclei
  153. PHOSPHORYLATION ON TYROSINE OF THE 173-ESTRADIOL RECEPTOR
  154. The Progesterone Receptor/Estradiol Receptor Association and the Progestin-Triggered S-Phase Entry